Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis-Reference-Cited by-同舟云学术

Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis

Published:2019-09 Issue: Volume:147 Page:104354
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Orsolini Giovanni,Fassio Angelo,Rossini Maurizio,Adami Giovanni,Giollo Alessandro,Caimmi Cristian,Idolazzi Luca,Viapiana Ombretta,Gatti Davide

Publisher

Elsevier BV

Subject

Pharmacology

Reference129 articles.

1. Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis;Zhang;Arthritis Rheum.,2010

2. Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis;Guler-Yuksel;Ann. Rheum. Dis.,2009

3. Reduced bone mineral density in early rheumatoid arthritis is associated with radiological joint damage at baseline and after 2 years in women;Forslind;J. Rheumatol.,2003

4. Relationship of focal erosions, bone mineral density, and parathyroid hormone in rheumatoid arthritis;Rossini;J. Rheumatol.,2011

5. Denosumab, cortical bone and bone erosions in rheumatoid arthritis;Rossini;Ann. Rheum. Dis.,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significant decrease of osteoporosis and osteoporotic fractures in rheumatoid arthritis within a period of 24 years: experiences of a single centre;RMD Open;2024-08

2. Actualización de las Guías para el Tratamiento Farmacológico de la Artritis Reumatoide del Colegio Mexicano de Reumatología 2023;Reumatología Clínica;2024-05

3. Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023;Reumatología Clínica (English Edition);2024-05

4. The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches;Clinical Rheumatology;2024-03-18

5. Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database;Bone;2024-02